31082410|t|Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5xFAD mouse model of Alzheimer's disease.
31082410|a|The role of mitochondrial dysfunction has been well-documented in Alzheimer's disease (AD). Glucagon-like peptide 1 (GLP-1) receptor agonists are being utilized as neuroprotectants in the treatment of various neurological disorders, including AD. We conducted this study to explore the effects of exenatide (a GLP-1 receptor agonist) on beta-amyloid plaque (Abeta)-induced cognitive impairment and mitochondrial dysfunction in 5xFAD transgenic mice. Spatial memory test showed that exenatide administration (100 mug/kg twice per day) prevented cognitive decline after 16 weeks of treatment. Abeta1-42 deposition and synapse damage in the hippocampus was significantly alleviated. Furthermore, exenatide treatment can improve mitochondrial morphology, relieve oxidative damage, correct mitochondrial energy crisis, and normalize mitochondrial dynamics. These findings suggest that exenatide, which has already been applied in clinical medicine, may be a promising agent for AD therapy via mitochondrial protection.
31082410	0	9	Exenatide	Chemical	MESH:D000077270
31082410	21	46	mitochondrial dysfunction	Disease	MESH:D028361
31082410	51	71	cognitive impairment	Disease	MESH:D003072
31082410	79	84	5xFAD	CellLine	CVCL:5U93
31082410	85	90	mouse	Species	10090
31082410	100	119	Alzheimer's disease	Disease	MESH:D000544
31082410	133	158	mitochondrial dysfunction	Disease	MESH:D028361
31082410	187	206	Alzheimer's disease	Disease	MESH:D000544
31082410	208	210	AD	Disease	MESH:D000544
31082410	238	253	GLP-1) receptor	Gene	14652
31082410	330	352	neurological disorders	Disease	MESH:D009461
31082410	364	366	AD	Disease	MESH:D000544
31082410	418	427	exenatide	Chemical	MESH:D000077270
31082410	431	445	GLP-1 receptor	Gene	14652
31082410	479	484	Abeta	Gene	11820
31082410	494	514	cognitive impairment	Disease	MESH:D003072
31082410	519	544	mitochondrial dysfunction	Disease	MESH:D028361
31082410	548	553	5xFAD	CellLine	CVCL:5U93
31082410	565	569	mice	Species	10090
31082410	603	612	exenatide	Chemical	MESH:D000077270
31082410	665	682	cognitive decline	Disease	MESH:D003072
31082410	737	751	synapse damage	Disease	MESH:D020263
31082410	814	823	exenatide	Chemical	MESH:D000077270
31082410	846	859	mitochondrial	Disease	MESH:D028361
31082410	906	919	mitochondrial	Disease	MESH:D028361
31082410	949	962	mitochondrial	Disease	MESH:D028361
31082410	1001	1010	exenatide	Chemical	MESH:D000077270
31082410	1094	1096	AD	Disease	MESH:D000544
31082410	1109	1122	mitochondrial	Disease	MESH:D028361
31082410	Negative_Correlation	MESH:D000077270	MESH:D028361
31082410	Negative_Correlation	MESH:D000077270	MESH:D000544
31082410	Negative_Correlation	MESH:D000077270	MESH:D003072
31082410	Positive_Correlation	MESH:D000077270	14652
31082410	Negative_Correlation	MESH:D000077270	MESH:D020263
31082410	Positive_Correlation	MESH:D003072	11820

